Skip to main content
. 2021 Oct 11;12:757041. doi: 10.3389/fimmu.2021.757041

Figure 4.

Figure 4

Comparison of NETs level in different groups. (A–C) ELA2, H3 and Syndecan-1 levels in groups of survivor and non-survivor patients. (D–F) ELA2, H3 and Syndecan-1 levels in groups of patients with or without DIC stratified by 28-day mortality. *p < 0.05, **p < 0.01, ****p < 0.0001.